Results 41 to 50 of about 355,580 (298)

European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen   +23 more
wiley   +1 more source

Optimization of Pearson Ⅲ Frequency Curve Based on R Software

open access: yesRenmin Zhujiang, 2021
The Pearson Ⅲ frequency curve is a common frequency curve in hydrological analysis process. Based on the 47-year annual runoff data of a hydrological station, this paper defines the optimal fitting parameters and frequency distribution curve according to
HE Mei, ZHAO Huarong, YAO Yue, JIN Xin
doaj  

Bayesian curve estimation by model averaging [PDF]

open access: yes, 2003
A bayesian approach is used to estimate a nonparametric regression model. The main features of the procedure are, first, the functional form of the curve is approximated by a mixture of local polynomials by Bayesian Model Averaging (BMA); second, the ...
Peña, Daniel, Redondas, María Dolores
core  

ynavott/curve-fitter: Initial Release

open access: yes, 2020
Initial release of my python curve-fitting ...
Yoav
core   +1 more source

Sigmoidal curve fitting example.

open access: yes, 2022
Sigmoidal curve fitting of 3 dilutions (1/50, 1/400, 1/3200) for 3 timepoints of the naturally infected subject #6 for the anti-RBD antibodies.
Carla Saade (13780597)   +6 more
core   +1 more source

Clinical and Biological Features of Response in Resistant Neuroblastoma to 131I‐Metaiodobenzylguanidine Radiotherapy in the Anti‐GD2 Immunotherapy Era

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background 131I‐metaiodobenzylguanidine (131I‐MIBG) radiotherapy is a key treatment for relapsed and refractory (R/R) neuroblastoma (NB). Patients with R/R disease treated in the modern era are increasingly exposed to anti‐GD2 immunotherapy, which exerts selective pressure and may modify both tumor cell state and microenvironment.
Benjamin J. Lerman   +7 more
wiley   +1 more source

The original curve and the fitting curve.

open access: yes, 2019
The original curve and the fitting curve.
Duan Liu (2506177)   +4 more
core   +1 more source

Venous Thromboembolism in Pediatric Bone Sarcoma Patients: A 10‐Year, Single‐Institution Experience Encompassing the COVID‐19 Pandemic

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Osteosarcoma (OS) and Ewing sarcoma (EWS) are the most common primary bone cancers in children, but acute thrombosis is poorly characterized in this population. Our study evaluated the rates of venous thromboembolism (VTE) and associated risk factors in pediatric patients with bone sarcomas treated over a 10‐year period encompassing
Sarah Kappa   +8 more
wiley   +1 more source

Mössbauer spectral curve fitting combining fundamentally different techniques

open access: yes, 2016
We propose the use of fundamentally distinctive techniques to solve the problem of curve fitting a Mössbauer spectrum. The techniques we investigated are: evolutionary algorithm, basin hopping, and hill climbing.
Ferry Susanto   +3 more
core   +1 more source

Serological Benefit of SARS‐CoV‐2 Vaccination Relative to Infection in Children With Acute Lymphoblastic Leukemia

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Children with acute lymphoblastic leukemia (ALL) are at risk of severe outcomes from SARS‐CoV‐2 (SCV2). In the post‐pandemic context, where most children have been infected with SCV2, there are limited data on whether vaccination remains beneficial in children with ALL.
Janna R. Shapiro   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy